I
316.43
-1.88 (-0.59%)
| 前收盘价格 | 318.30 |
| 收盘价格 | 317.97 |
| 成交量 | 85,053 |
| 平均成交量 (3个月) | 626,893 |
| 市值 | 22,273,957,888 |
| 市盈率 (P/E TTM) | 96.47 |
| 预期市盈率 (P/E Forward) | 54.95 |
| 价格/销量 (P/S) | 9.57 |
| 股市价格/股市净资产 (P/B) | 15.03 |
| 52周波幅 | |
| 利润日期 | 6 Nov 2025 |
| 营业毛利率 | 18.29% |
| 营业利益率 (TTM) | 15.61% |
| 稀释每股收益 (EPS TTM) | 5.54 |
| 季度收入增长率 (YOY) | 28.80% |
| 季度盈利增长率 (YOY) | -31.30% |
| 总债务/股东权益 (D/E MRQ) | 131.40% |
| 流动比率 (MRQ) | 4.47 |
| 营业现金流 (OCF TTM) | 406.50 M |
| 杠杆自由现金流 (LFCF TTM) | 84.25 M |
| 资产报酬率 (ROA TTM) | 6.94% |
| 股东权益报酬率 (ROE TTM) | 37.92% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | Insulet Corporation | 看涨 | 看涨 |
AIStockmoo 评分
-0.5
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | -2.0 |
| 平均 | -0.50 |
|
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Mid Growth |
| 内部持股比例 | 0.29% |
| 机构持股比例 | 102.56% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 399.00 (Canaccord Genuity, 26.10%) | 购买 |
| 中 | 357.50 (12.98%) | |
| 低 | 300.00 (Barclays, -5.19%) | 保留 |
| 平均值 | 355.67 (12.40%) | |
| 总计 | 5 购买, 1 保留 | |
| 平均价格@调整类型 | 320.14 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Stifel | 21 Oct 2025 | 370.00 (16.93%) | 购买 | 318.59 |
| Canaccord Genuity | 29 Sep 2025 | 399.00 (26.10%) | 购买 | 310.62 |
| 08 Aug 2025 | 353.00 (11.56%) | 购买 | 307.10 | |
| Oppenheimer | 08 Sep 2025 | 365.00 (15.35%) | 购买 | 349.56 |
| Barclays | 21 Aug 2025 | 300.00 (-5.19%) | 保留 | 327.85 |
| RBC Capital | 08 Aug 2025 | 350.00 (10.61%) | 购买 | 307.10 |
| Wells Fargo | 08 Aug 2025 | 350.00 (10.61%) | 购买 | 307.10 |
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 10 Oct 2025 | 公告 | Insulet to Host Investor Day on November 20, 2025 |
| 18 Sep 2025 | 公告 | Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette |
| 16 Sep 2025 | 公告 | Insulet Announces CFO Transition |
| 25 Aug 2025 | 公告 | Insulet Elevates Eric Benjamin to Chief Operating Officer |
| 19 Aug 2025 | 公告 | Insulet to Participate in Upcoming Investor Conferences |
| 07 Aug 2025 | 公告 | Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency¹) |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合